| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-24 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |